Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Ansornitinib

😃Good
Catalog No. T63809Cas No. 1448874-96-1
Alias ANG-3070, ANG3070, ANG 3070

Ansornitinib (ANG-3070) is an orally active KDR and PDGF receptor inhibitor with antifibrotic activity that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2), and may be useful for the study of diseases caused by abnormal or excessive fibrosis.

Ansornitinib

Ansornitinib

😃Good
Catalog No. T63809Alias ANG-3070, ANG3070, ANG 3070Cas No. 1448874-96-1
Ansornitinib (ANG-3070) is an orally active KDR and PDGF receptor inhibitor with antifibrotic activity that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2), and may be useful for the study of diseases caused by abnormal or excessive fibrosis.
Pack SizePriceAvailabilityQuantity
1 mg$1436-8 weeks
5 mg$3186-8 weeks
10 mg$4976-8 weeks
25 mg$1,0706-8 weeks
50 mg$1,6906-8 weeks
100 mg$2,5006-8 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Ansornitinib (ANG-3070) is an orally active KDR and PDGF receptor inhibitor with antifibrotic activity that inhibits platelet-derived growth factor receptor (PDGFR) and vascular endothelial growth factor receptor (VEGFR2), and may be useful for the study of diseases caused by abnormal or excessive fibrosis.
In vitro
Ansornitinib, at concentrations ranging from 0.1 nM to 10 μM, significantly inhibits the phosphorylation of PDGFRβ in human hepatic stellate cells and KDR phosphorylation in human umbilical vein endothelial cells (HUVECs) within 2 hours[1].
In vivo
In 8-10 weeks TGFβ positive female mice, Ansornitinib ( 25 mg / kg ; oral administration ; twice a day ; 4 weeks ) could reduce lung fibrosis score, lung levels and αSMA, a marker of early pulmonary fibrosis[1].
AliasANG-3070, ANG3070, ANG 3070
Chemical Properties
Molecular Weight540.61
FormulaC30H32N6O4
Cas No.1448874-96-1
Storage & Solubility Information
Storagestore at -20°C | Shipping with blue ice.
Solubility Information
DMSO: 20 mg/mL (36.00 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8498 mL9.2488 mL18.4976 mL92.4881 mL
5 mM0.3700 mL1.8498 mL3.6995 mL18.4976 mL
10 mM0.1850 mL0.9249 mL1.8498 mL9.2488 mL
20 mM0.0925 mL0.4624 mL0.9249 mL4.6244 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Ansornitinib | purchase Ansornitinib | Ansornitinib cost | order Ansornitinib | Ansornitinib chemical structure | Ansornitinib in vivo | Ansornitinib in vitro | Ansornitinib formula | Ansornitinib molecular weight